Vascular attack and immunotherapy: a ‘two hits’ approach to improve biological treatment of cancer
Open Access
- 1 February 1999
- journal article
- editorial
- Published by Springer Nature in Gene Therapy
- Vol. 6 (2) , 153-154
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Evidence for the involvement of endotheliai cell integrin αVβ3 in the disruption of the tumor vascuiature induced by TNF and IFN-γNature Medicine, 1998
- Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cellsNature Medicine, 1998
- Antiangiogenic therapy of experimental cancer does not induce acquired drug resistanceNature, 1997
- Targeting by affinity–matured recombinant antibody fragments of an angiogenesis associated fibronectin isoformNature Biotechnology, 1997
- The host—tumor immune conflict: from immunosuppression to resistance and destructionImmunology Today, 1997
- Tumor antigens recognized by T cellsImmunology Today, 1997
- Murine tumor antigens: is it worth the search?Current Opinion in Immunology, 1996
- THE ROLE OF CXC CHEMOKINES AS REGULATORS OF ANGIOGENESISShock, 1995
- Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vesselsCell, 1994
- Homing of naive, memory and effector lymphocytesCurrent Opinion in Immunology, 1993